Table 1.
Mouse lung lipid mediators (pg/lung)
| Q1 | Q3 | 0 hrs |
SEM |
24 hrs |
SEM |
72 hrs |
SEM |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RvD1 | 375 | 141 | 0.4 | ± | 0.1 | 1.6 | ± | 0.4 | 5.1 | ± | 1.6 |
| RvD2 | 375 | 175 | 0.8 | ± | 0.3 | 10.7 | ± | 3.7 | 36.4 | ± | 12 |
| RvD3 | 375 | 147 | 0.2 | ± | 0.1 | 1.2 | ± | 0.5 | 2.7 | ± | 1 |
| RvD5 | 359 | 199 | 16.2 | ± | 7.8 | 14.8 | ± | 6.8 | 35.2 | ± | 4.5 |
| RvD6 | 359 | 159 | 2.4 | ± | 0.3 | 2.7 | ± | 0.4 | 6.8 | ± | 1.1 |
| AT-RvD1 | 375 | 141 | 0.6 | ± | 0.2 | 3.3 | ± | 1.1 | 6.7 | ± | 1.4 |
| AT-RvD3 | 375 | 147 | * | * | * | * | * | * | |||
| PD1 | 359 | 153 | 0.7 | ± | 0.1 | 2.5 | ± | 0.7 | 3.8 | ± | 0.8 |
| 10S,17S-diHDHA | 359 | 153 | 41.7 | ± | 23.6 | 209.9 | ± | 119.2 | 394.1 | ± | 58.5 |
| AT-PD1 | 359 | 153 | 0.8 | ± | 0.2 | 4.2 | ± | 1 | 8.7 | ± | 4.5 |
| MaR1 | 359 | 177 | 0.7 | ± | 0.3 | * | ± | * | * | ± | * |
| RvE1 | 349 | 161 | * | ± | * | * | ± | * | * | ± | * |
| RvE2 | 333 | 253 | 4.5 | ± | 0.6 | 4.9 | ± | 1.6 | 42.7 | ± | 20.1 |
| RvE3 | 333 | 201 | 5.4 | ± | 1.3 | 66 | ± | 22 | 199.3 | ± | 48.2 |
| LxA4 | 351 | 115 | 4.5 | ± | 1.9 | 49.2 | ± | 24 | 102.4 | ± | 54.1 |
| LxB4 | 351 | 221 | 123.5 | ± | 0.6 | 696.6 | ± | 1.6 | 1094 | ± | 20.1 |
= below limit (0.1pg)